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A group of 72 patients with 111 asymptomatic carotid stenoses (ACS), mean age 65.42 ± 
9.21, and a group of 36 patients with 58 symptomatic carotid stenoses (SCS), mean age 
67.63 ± 8.79, were analyzed prospectively during a 3-year follow-up period. All patients 
underwent color duplex scan sonography (CDS), carotid arteriography, computed 
tomography (CT) scan, and neurological examination. The aim of the study was to 
analyze the correlation between echo plaque morphology (degree and plaque quality), 
local hemodynamic plaque characteristics, ischemic CT findings, and onset of new 
neurological events and deaths. The results analysis showed significantly more ACS in 
the group of 30–49% stenosis (p < 0.001), but significantly more SCS in the group of 70–
89% (p < 0.0001) and ≥90% stenosis (p < 0.05). Fibrous plaque was more frequent in the 
ACS group (p < 0.001), while ulcerated and mixed plaques were more frequent in the SCS 
group (both p < 0.0001). In the SCS group, a significantly higher frequency of increased 
peak systolic and end diastolic velocities was noted at the beginning and end of the 
study (both p < 0.01), as well as for contralateral common (CCA) or internal carotid artery 
(ICA) occlusion (p < 0.05 and p < 0.01, respectively), but reduced carotid blood flow 
volume (p < 0.05) only at the end of the study. In the ACS group, the best correlation with 
new neurological events and deaths was shown with positive CT findings, peak systolic 
flow velocity over 210 cm/sec, end diastolic flow velocity over 110 cm/sec, plaque 
stenosis ≥70%, plaque ulceration, mixed plaque (all p < 0.0001); stenosis ≥50% (p < 
0.001); and reduced carotid blood flow volume (p < 0.05). 
KEYWORDS: carotid stenosis, carotid plaque, cerebrovascular disorders, neurological 
symptoms, stroke, ultrasonography, angiography, X-ray computed tomography, color duplex 
scanning, peak flow velocities 
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INTRODUCTION 
Nowadays, timely diagnosis and treatment of cerebrovascular ischemic disease (CVID) are among the 
most important medical concerns. There are several reasons for this, but the most important is the fact that 
stroke, mainly as a consequence of CVID, is one of the most frequent causes of death[1]. Serious 
disability after stroke due to irreversible damage of the brain with limited possibility for rehabilitation 
requires permanent care by another person. In some countries, stroke is the major health problem, with 
high incidence and serious social and economic consequences[2]. The unsatisfactory results of immediate 
and late stroke treatment require researchers to devise better neuroprotection therapies for ischemic 
stroke[3]. 
In the U.S., stroke ranks No. 3 among all causes of death, behind diseases of the heart and cancer. 
Among adults, ages 20 and older, the estimated prevalence of stroke in 2005 was 5,800,000, and new or 
recurrent stroke attacks are experienced each year by 780,000 people[4]. These data illustrate the 
importance of timely diagnosis and treatment in early stages of CVID. 
Studies of carotid atherosclerosis[5] showed that patients with moderate or severe carotid stenosis 
were often without transient ischemic attacks (TIA) and were asymptomatic for a long time, but 
eventually experienced stroke. The Harvard Cooperative Stroke Registry presented that 74% of strokes 
happened without warning, and 50% of all strokes were due to carotid or vertebral artery thrombosis in 
patients without TIA. In 75% of ischemic strokes due to carotid atherosclerosis proved by carotid 
arteriography, 35% had not been preceded by TIA[6]. 
The fact that nearly 50% of all strokes happened due to embolus or thrombosis of extracranial 
segments of carotid or vertebral arteries recognizes that color duplex scanning of carotid and vertebral 
arteries is an appropriate and highly accurate diagnostic method[7]. 
The aim of this study was to analyze relationships between echo plaque morphological features 
(degree of the stenosis, echo plaque surface, and composition qualities), on the one hand, and local 
hemodynamic flow features (carotid flow reduction on the affected side, presence and influence of 
contralateral occlusion of internal or common carotid artery, peak systolic and end diastolic flow 
velocities on the stenosis site), on the other, with onset of neurological events (neurological symptoms 
and objective findings of neurological disorders) and deaths. 
MATERIALS AND METHODS 
Seventy-two patients (pts) with 111 asymptomatic carotid stenoses (ACS) and 36 pts with 58 
symptomatic carotid stenoses (SCS) were prospectively studied. Only carotid stenoses equaling 30% of 
the cross-sectional area or more were included in the analysis. The ACS group was composed of 49 males 
and 23 females, mean ages 66.7 and 62.3 years, respectively; and the SCS group included 28 males and 8 
females, mean ages 68.2 and 62.4 years, respectively. In 39 pts with ACS, stenoses were present on both 
carotid arteries, and in 33 pts, on one carotid artery. In the SCS group, 22 and 14, respectively. ACS 
implied stenosis of common (CCA) or internal carotid artery (ICA) among the pts without any 
neurological symptoms, as well as objective neurological disorder until the moment of enrollment into the 
study. SCS implied patients with documented history of TIA, amaurosis fugax (AF), reversible ischemic 
neurological deficit (RIND), progressive (PIND) or chronic (CIND) ischemic neurological deficit 
attributable to carotid artery stenosis. The exclusion criteria covered pts with diagnoses of absolute 
arrhythmia, left ventricular (LV) or atrial thrombus, LV diastolic size exceeding 7 cm and LV ejection 
fraction below 30%, left atrial systolic size exceeding 5 cm, dilatative cardiomyopathy, and infective 
endocarditis and state after implantation of artificial heart valves.  
Color duplex scan (CDS) examinations were performed in the Zvezdara University Hospital echo 
laboratory at the beginning of the study, after 3 and 6 months, and then in 6-month intervals to the end of 
the 3-year follow-up. 
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All scans were performed with a vascular linear 7-MHz duplex scan head, using an Acuson Aspen 
Advanced Ultrasound machine. All subjects were examined in the supine position with slight head 
extension. Degree of stenosis was calculated by the ratio of the cross-sectional area of stenosis to cross-
sectional area of whole artery at the site of maximal stenosis, expressed in percents. Analysis of the 
plaque quality took into account the estimation of plaque surface and echo composition, using the cross-
sectional and longitudinal projections obtained by the anterior, lateral, and posterolateral projections to 
obtain images of the plaques. Plaque quality echo features were defined as: calcified – high echoic with 
distal acoustic shadows; fibrous – uniformly echoic without acoustic shadows; intraplaque hemorrhage – 
uniformly echolucent with echoic fibrous cap on the border of the plaque; mixed (heterogeneous) – both 
echolucent and echoic areas in the same plaque with more than 50% echoic zone; ulceration – the 
discontinuation of fibrous cap presented as an interruption of its echogenity (Fig. 1).  
       
A               B 
FIGURE 1. Ulcerated plaque with big embolic potential (A). Color inflow inside of the plaque (B). 
Local flow features at the site of carotid stenosis were analyzed by pulse wave color Doppler flow 
measurements: peak systolic velocity (PSV) and end diastolic velocity (EDV) in centimeters per second 
(cm/sec); blood flow volume was calculated using values of peak systolic velocity, flow velocity integral, 
cross-sectional area surface at the site of stenosis, and heart rate. A significant blood flow reduction was 
defined as the flow below 200 ml/min in the carotid communal and/or carotid internal artery. Occlusion 
of the contralateral CCA or ICA was defined as the absence of flow in the affected artery. 
All pts underwent panarcography and selective carotidography at the beginning and end of the 3-year 
follow-up. A seriographic Siemens machine was used, and degree of stenosis was estimated by the Barnes 
method using anteroposterior, left, and right oblique projections. 
All pts underwent cerebral computed tomography (CT) examination at the beginning and each year 
until the end of the follow-up. The examinations were performed by a CT Pace Plus General Electric 
machine. Ten-section planes per 10 mm from the skull baseline were analyzed – clear hypodense lesions 
ipsylateral with the carotid stenosis were considered as ischemic cerebral infarction (CVI). 
Neurological examinations were performed by a neurologist who established types of neurological 
events: AF – implying transient monocular blindness; TIA – implying a brief episode of neurological 
disfunction, such as hemiparesis, hemiparestesia, dysarthria, dysphasia completely reversibile up to 24 h 
from onset; stroke – implying persistent hemiparesis or hemiplegia, with or without speech disturbances 
due to CVI. 
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To establish the presence of cardiovascular risk factors (RF), coronary artery disease (CAD), and 
peripheral occlusive arterial disease (POAD) on lower legs, all pts underwent the following diagnostic 
procedures: for CAD – selective coronarography at the beginning of the study, where significant stenosis 
was defined as at least 50% of one of the coronary arteries; for POAD – measuring the ankle brachial 
pressure index of lower extremities at the beginning of the study, with significant values below 0.90 on at 
least one leg; for general RF – assessment of the presence of arterial hypertension, smoking, and diabetes 
mellitus history; higher LDL and triglycerides; and lower HDL blood levels. Systolic and diastolic blood 
pressure measurements were performed at the beginning and end of the study, manually with a mercury 
sphyngomanometer with three consecutive readings, at least 1 week apart. The diagnosis of arterial 
hypertension was based on mean systolic blood pressure exceeding 140 mmHg and/or diastolic exceeding 
90 mmHg. Serum lipid concentrations were measured after 12-h fasting at the beginning and end of the 
study. LDL was estimated using the Friedwald equation and standard assays for total cholesterol, HDL, 
and triglycerides. Higher values were set: LDL ≥3.5 mmol/l, triglycerides ≥1.7 mmol/l, and HDL ≤1.3 
mmol/l.  
Statistical Analysis 
Differences between mean values were analyzed using student t-test. Differences between degree of 
stenosis, plaque quality, TIA, AF, stroke, deaths, ischemic lesions on CT findings between ACS and SCS 
groups were established using Chi-square and Fisher test, with level of significance set at p < 0.05. In 
cases with frequency below five, we used Yates correction. Correlations between the groups of stenosis 
degree, plaque quality, peak systolic and end diastolic velocity, blood flow volume, and onset of 
neurological events and deaths frequency among the ACS and SCS group were performed using 
Spierman correlation (correlation coefficient = R; p = level of significance), and Kruskal-Wallis one-way 
analysis of variance (Kruskal Wallis test value = H; p = level of significance). 
Stroke frequency during the follow-up was presented as stroke-free interval using Kaplan Mayer life 
table analysis. The diagnostic value of CDS technique was assessed in relation to results of carotid 
arteriography by calculations of sensitivity (Sz), specificity (Sc), and diagnostic accuracy (Ac) using the 
following formulas:   
Sz = TrP/(TrP+FN) × 100 
Sc = (TrN)/(TrN+FP) × 100 
Ac = (TrP+TrN)/(ToP+ToN) × 100 
TrP = true positive, FP = false positive, TrN = true negative, FN = false negative, ToP = total positive 
(true positive + false positive), ToN = total negative (true negative + false negative). 
RESULTS  
The mean age of the SCS group was significantly higher than in the ACS group (Table 1). 
The analysis of the cardiovascular risk factors showed that the frequency of smoking and lower HDL 
level were significantly higher in the SCS vs. ACS group, while the mean values of the diastolic pressure 
were significantly higher in the ACS group and higher LDL level in SCS group at the beginning of the 
study (Table 1).  
Among the risk factors, only lower HDL level showed significant association with the mix of all 
unstable plaque types in the ACS group (Table 2). 
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TABLE 1 
Demographics, Clinical Characteristics, and Risk Factors of ACS and SCS Groups  
Variables [Mean ± S.D. or No. (%)] ACS (n = 111) SCS (n = 58) p(χ2) 
Age 64.4 ± 9 67.6 ± 10 0.001* 
Male 78 (70%) 45 (78%) 0.310 
Female  33 (30%) 13 (22%) 0.543 
Arterial hypertension 73 (66%) 45 (78%) 0.112 
Systolic 158.6 ± 27.7 165.4 ± 23.9 0.113* 
Diastolic 86.9 ± 15.5 80.8 ± 12.4 0.010* 
Higher LDL (≥3.5 mmol/l)  54 (49%) 31 (53%) 0.555 
LDL 3.40 ± 0.45 3.61 ± 0.46 0.005* 
Lower HDL (≤1.3 mmol/l) 52 (47%) 41 (71%) 0.003 
HDL 1.39 ± 0.31 1.32 ± 0.36 0.181* 
Higher triglycerides (≥1.7 mmol/l) 38 (34%) 73 (66%) 0.360 
Triglycerides 1.74 ± 0.56 1.62 ± 0.59 0.183* 
Diabetes mellitus 55 (50%) 37 (64%) 0.077 
Smoking 67 (60%) 44 (76%) 0.043 
CAD  46 (41%) 22 (38%) 0.658 
POAD 61(55%) 24(41%) 0.093 
ABPI 0.84 ± 0.22 0.82 ± 0.24 0.544* 
Renal failure  4 (4%) 2 (3%) 0.935 
Medications after entering the study    
Acetylsalicylic acid    101 (91%) 54 (93%) 0.857 
Clopidogrel 34 (31%) 15 (26%) 0.516 
Statins 108 (97%) 57 (98%) 0.894 
β-Blockers 87 (78%) 41 (71%) 0.268 
Long-acting nitrates 52 (47%) 21 (36%) 0.184 
ACE inhibitors 77 (69%) 48 (82%) 0.059 
Diuretics  28 (25%) 23 (40%) 0.052 
Calcium channel antagonists 15 (14%) 10 (17%) 0.516 
Antidiabetics  55(60%) 37(64%) 0.077 
CEA 12 (11%) 38 (66%) 0.000 
All events + deaths after CEA 0 + 1 (1%) 8 + 0 (14%) 0.000 
Total deaths  2 (2%) 3 (5%) 0.453 
* t-Test value; CAD, coronary artery disease; POAD, peripheral occlusive arterial 
disease; ABPI, ankle-brachial pressure index; CEA, carotid endarterectomy 
CAD, POAD, and chronic renal failure frequency did not differ between the groups (Table 1).  
There were no significant differences between the two groups in the aspect of number of pts taking 
the same medications after they entered the study. The number of carotid endarterectomy operations, and 
neurological events and deaths, among the patients after surgery were significantly higher in the SCS vs. 
ACS group (Table 1).  
After 36 months, the number of asymptomatic stenoses was significantly higher in the 30–49% 
stenosis degree group; the same applies to symptomatic stenoses in 70–89% and over 90% stenoses 
groups (Table 3). 
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TABLE 2 
Association between the Risk Factors and Unstable Carotid Type Plaques   
ACS (n = 111)* SCS (n = 58) Risk Factors 
ACS 
(n) 
Mixed p Ulcer p SCS 
(n) 
Mixed p Ulcer p IPH p 
Smoking Yes 67 14 0.95 9 0.22 44 21 0.43 17 0.23 4 0.44 
 No 44 9  2  14 9  7  3  
AHT Yes 73 16 0.66 7 0.85 45 23 0.86 16 0.91 4 0.86 
 No 38 7  4  13 7  8  3  
LDL Yes 54 14 0.18 7 0.46 31 15 0.58 12 0.88 3 0.84 
 No 57 9  4  27 15  12  4  
HDL Yes 42 17 0.0001 6 0.38 31 19 0.11 14 0.53 2 0.16 
 No 69 6  5  27 11  10  5  
DM Yes 55 12 0.77 6 0.72 37 16 0.08 10 0.38 5 0.97 
 No 56 11  5  21 14  14  2  
TGD Yes 38 10 0.60 4 0.85 24 13 0.75 10 0.97 3 0.74 
 No 73 13  7  34 17  14  4  
* IPH was not taken into account because of only three cases; p values associated with χ2 test; AHT, arterial 
hypertension; DM, diabetes mellitus; TGD, triglycerides. 
TABLE 3 
Number of Stenoses According to the Stenosis Degree  
after 36 Months 
Stenosis  АCS SCS χ2 p 
30–49% 30 (27%) 2 (3%) 13.80 0.0002 
50–69% 57 (51%) 21 (36%) 3.52 0.0608 
70–89% 19 (17%) 27 (47%) 16.66 0.00001 
>90% 5 (5%) 8 (14%) 4.63 0.0314 
After 36 months, the number of new stenoses over 70% was significantly higher only in the SCS 
group (Table 4). After 36 months, the number of fibrous plaques was significantly higher in the ACS 
group; the same applies to mixed and ulcerated plaques in the SCS group (Table 5). Ulcerated plaques 
had a significant influence on the onset of neurological events and deaths in both groups; the same applies 
to mixed plaques in the ACS group (Table 6).        
The number of contralateral CCA or ICA occlusions was significantly higher in the SCS group, at the 
beginning as well as at the end of the study (Table 7). The number of carotid stenoses with reduced 
carotid blood flow volume was significantly higher in the SCS group at the end of study (Table 8). 
Number of cases with peak systolic velocities over 130 and 210 cm/sec, as well as end diastolic velocities 
over 40 and 110 cm/sec, was significantly higher in the SCS than in the ACS group (Tables 9 and 10). 
After 12, 24, and 36 months, the number of CVI and all neurological events was significantly higher in 
the SCS group, as well as number of CVI and deaths after 12 and 36 months (Table 11). During the follow-
up period, the number of CVI and deaths rose significantly only in the SCS group (Table 12). Time 
distribution of stroke has shown a higher frequency among SCS pts (Graph 1). During the follow-up in the 
ACS group, the mixed plaques were significantly more frequent in pts with new neurological events, fibrous  
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ТАBLE 4 
Occurrence of New ≥70% Stenoses during the Follow-Up  
Time АCS SCS χ2 p 
Start 17 (15%) 19 (32%) 0.78 0.3773 
36 months 22 (20%) 31 (53%) 5.06 0.0245 
ТАBLE 5 
Number of Various Plaque Types at the End of Follow-Up 
Plaque Type АCS SCS χ2 p 
Calcified 29 (26%) 9 (16%) 2.46 0.1168 
Fibrous 48 (43%) 10 (17%) 11.43 0.0007 
Hemorrhage 0 1 (2%) 1.97 0.1653 
Мix 30 (27%) 38 (65%) 23.47 0.00001 
Ulcerated  12 (11%) 31 (53%) 36.59 0.00001 
ТАBLE 6 
Frequency of Various Unstable Plaque Types and Their Relations to Onset  
of All New Neurological Events and Deaths during the Follow-Up  
Groups   Hemorrhage Mixed Ulcerated New Events 
ACS Number 3 23 11 11 
 H 0.0001 15.87 16.90  
 
p 1.0 0.00001 0.00001  
SCS Number 7 30 24 23 
 H 1.41 2.29 4.11  
 p 0.233 0.129 0.042  
TABLE 7 
Contralateral CCA or ICA Occlusion at the  
Beginning and End of the Study 
Groups Start 36 Months 
ACS occlusion 2 (2%) 3 (3%) 
SCS occlusion 5 (9%) 9 (16%) 
χ2 4.46 7.64 
p 0.0347 Yates 0.0057 
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TABLE 8 
Number of Reduced Carotid Blood Flow Cases  
at the Beginning and End of the Study 
Groups Start 36 Months 
ACS reduced flow 4 (4%) 4 (4%) 
SCS reduced flow 5 (9%) 8 (14%) 
χ2 1.90 4.55 
p 0.167 Yates 0.0329 
TABLE 9 
Frequency of Increased Maximal Peak Systolic and End Diastolic Velocities of Examined  
Carotid Stenoses at the Beginning and End of the Study 
EDV >40 cm/sec  Start 36 Months PSV >130 cm/sec Start 36 Months 
ACS 23 (21%) 28 (25%) ACS 39 (35%) 47 (42%) 
SCS 23 (40%) 36 (62%) SCS 35 (60%) 44 (76%) 
χ2 6.89 21.98 χ2 9.84 17.22 
p 0.0087 0.00001 p 0.0017 0.0001 
TABLE 10 
Frequency of Increased Maximal Peak Systolic and End Diastolic Velocities of Examined  
Carotid Stenoses at the Beginning and End of the Study 
EDV >110 cm/sec  Start 36 Months PSV >210 cm/sec Start 36 Months 
ACS 4 (4%) 9 (8%) ACS 11 (10%) 12 (11%) 
SCS 9 (16%) 14 (24%) SCS 14 (24%) 23 (40%) 
χ2 7.61 8.33 χ2 6.12 19.30 
p 0.0058 0.0034 p 0.0134 0.0001 
were borderline significant, but calcified plaques were significantly increased in new neurological event-
free pts (Table 13). At the end of the study, the total number of ischemic CT findings was significantly 
higher in the SCS group, and so was the number of new ischemic CT findings during the follow-up 
(Table 14). 
Correlation of every single examined local morphologic and hemodynamic carotid plaque 
characteristic and ischemic CT findings on the one hand, with onset of all neurological events and deaths 
on the other, was significant for positive CT findings, peak systolic velocity over 210 cm/sec, peak end 
diastolic velocity over 110 cm/sec, stenosis ≥70%, ulcerated plaque, mixed plaque, stenosis ≥50%, and 
carotid blood flow reduction (Table 15).  
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ТАBLE 11 
Number of Neurological Events after 12, 24, and 36 Months in ACS and SCS Groups 
Neurological Events 12 Months 24 Months 36 Months 
АCS ТIА 1 (1%) 4 (4%) 9 (8%) 
АCS СVI 0 1 (1%) 3 (3%) 
АCS АF 1 (1%) 1 (1%) 1 (1%) 
All events 2 (2%) 6 (5%) 12 (11%) 
SCS ТIА 5 (9%) 10 (17%) 20 (34%) 
SCS CVI 5 (9%) 8 (14%) 12 (21%) 
SCS АF 1 (1%) 3 (5%) 6 (11%) 
All events 11 (19%) 21 (36%) 38 (66%) 
АCS:SCS all events χ2 = 13.26; р = 0.0003 χ2 = 26.92; р = 0.00001 χ2 = 52.34; р = 0.00001 
АCS:SCS CVI χ2 = 7.23; р = 0.0072* χ2 = 10.13; р = 0.0015* χ2 = 13.10; р = 0.0003* 
* Yаtes correction. 
TABLE 12 
CVI and Death Frequency after 12 and 36 Months Follow-Up  
Groups 12 Months 36 Months χ2 p 
ACS 2 (2%) 5 (4%) 0.59* 0.4424 
SCS 5 (9%) 15 (26%) 4.89* 0.0270 
χ2 4.46 16.65*   
р 0.047 0.00001   
* Yates correction; Fisher test. 
TABLE 13 
Frequency of New Neurological Events According to ACS  
Plaque Types after 36 Months  
ACS Plaque 
Types 
Calcified Fibrous Hemorrhage Mixed 
Without symptoms 32 41 2 14 
All neuro events 0 3 1 9 
χ2 4.49 3.79 0.32 19.71 
p 0.034 0.050 >0.05 0.00001 
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ТАBLE 14 
Number of Ischemic CT Lesions in ACS and SCS  
at the Beginning and End of the Study 
CT Lesions Start 36 Months χ2 p 
АCS  25 (23%) 29 (27%) 0.34 0.5315 
SCS  16 (27%) 34 (60%) 11.39 0.0007 
χ2 0.53 17.20   
p 0.4659 0.00001   
TABLE 15 
Correlations of Local Risk Factors and Neurological Events and Deaths in ACS  
Variance Analysis 
(Kruskal Wallis) 
Correlation 
(Spierman) 
ACS Risk Factors 
H p R p 
CT lesion 37.55 0.00001 0.639 0.0000001 
PSV >210 cm/sec 35.34 0.00001 0.567 0.0000001 
EDV >110 cm/sec 25.79 0.00001 0.484 0.0000001 
Stenosis ≥70% 19.75 0.00001 0.424 0.000004 
Plaque ulceration 16.90 0.00001 0.392 0.000021 
Mixed plaque 15.87 0.00001 0.380 0.000039 
Stenosis ≥50% 11.23 0.0008 0.320 0.00062 
Reduced blood flow 5.21 0.022 0.218 0.0217 
Contralateral occlusion 1.19 0.273 0.104 0.2770 
Plaque hemorrhage 0.0001 1.0 / / 
 
GRAPH 1. Stroke distribution during the follow-up period. 
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Referring to our carotid arteriography findings, we assessed the diagnostic value of the CDS 
technique in terms of carotid stenosis degree and found 101 true positive, zero true negative, one false 
positive, and nine false negative results. Based on these findings, we calculated that the Sz, Sc, and Ac 
were 92, 90, and 92%, respectively. 
DISCUSSION  
The general cardiovascular risk factors are present in both carotid stenoses groups, in great extent 
contributing to the development of the carotid as well as coronary and peripheral artery atherosclerosis 
process. For most risk factors, there were no significant differences between the two groups except for the 
lower HDL level and smoking history frequency, as well as significantly higher LDL level in the SCS 
group at the beginning of the study. This could be explained by the fact that symptomatic stenoses were 
of high grade, with more complicated atherosclerotic plaques, which required the presence and greater 
influence of the main cardiovascular risk factors. 
The association of all risk factors in the ACS and SCS group with plaque ulceration, mixed plaque, 
and intraplaque hemorrhage presence was tested respectively and the significant influence was found only 
for lower HDL level on mixed type plaque in the ACS group (Table 2). HDL is one of the relevant risk 
factors involved in the development of atherosclerosis, acting as the acceptor of cholesterol released from 
tissues outside the liver, transporting it back to the liver, and decreasing the risk of thrombosis. The 
Veterans Affairs HDL Intervention Trial provided the evidence that an increase in HDL significantly 
decreased the incidence of coronary heart disease–related events and stroke[27]. 
In the ACS group, the frequency of mild degree stenoses was significantly higher than in the SCS 
group, but in the SCS group, the frequency of severe stenoses and frequency of newly diagnosed stenoses 
≥70% was significantly higher than in the ACS group. The increase of carotid stenosis degree is 
connected with atherosclerosis complications and local hemodynamic changes, which all could result in 
manifestation of neurological symptoms. AbuRahma et al.[8] and Norris and Zhu[9] reported that 
thromboembolic accidents increased with carotid stenosis degree and for stenoses ≥70%, these were 3–
5% annually, but for stenoses below 50%, it is minimal[8,9]. Among the 75–90% stenoses, unstable 
plaque was more frequent and associated with a higher risk of thromboembolic accidents[9]. Takaya et al. 
found that pts who initially had an asymptomatic 50–79% carotid stenosis were frequently associated 
with occurrence of subsequent cerebrovascular events[10]. 
In the SCS group, the mixed and ulcerated type plaques were significantly more frequent than in the 
ACS group, but the fibrous type plaque was significantly more frequent in the ACS group. Plaque 
ulceration is a source of microthrombosis and subsequent embolization resulting in symptom 
manifestation. Hipoechoic plaque often presents an intraplaque hemorrhage, which can result in fibrous 
cap rupture and plaque ulceration. Fisher et al.[11] reported 34% cases with ulcerated plaques in pts with 
neurological symptoms, in comparison to 14% in asymptomatic pts; Mathiesen et al.[12] found that echo-
rich plaques carry a lower risk of neurological symptoms. Thromboembolic events are significantly more 
frequent among the intraplaque hemorrhage, mixed, and ulcerated type of plaques than among fibrous and 
calcified plaques[13,14,15]. Steinke et al. studied a group of the severe stenoses (>80%), and found 
significantly more ulcerated plaques in the symptomatic (43%) than in asymptomatic stenoses (23%), but 
fibrous plaques were significantly more common in asymptomatic (46%) than in symptomatic stenoses 
(29%)[16]. Mayor et al. studied moderate and high-grade isoechoic and hyperechoic stenoses, and 
reported a significantly lower frequency of microembolic signals than in anechogenic and hipoechogenic 
lesions[17]. 
The number of CCA or ICA contralateral occlusions was significantly higher in the SCS group and 
showed that this risk factor importantly contributes to the onset of neurological symptoms. Some authors 
reported that the prevalence of contralateral CCA or ICA occlusion is about 5–8%, and is associated with 
triple accumulated relative risk for CVI[18]. 
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Hemodynamically reduced blood flow on the affected side was more frequent in the SCS group due 
to the presence of more severe-degree stenoses in this group. Fowl et al. showed that the prevalence of 
hemodynamically significant carotid stenoses in ACS pts was below 6%[19]. Powers reported that poor 
collateral circulation contributes to focal cerebral symptoms[20]. High flow velocity at the site of stenosis 
was more frequent in symptomatic than in asymptomatic cases. The significant rise of peak flow velocity 
is a consequence of high-degree carotid stenosis. The jet of flow at the site of maximal stenosis can 
produce intimal damage and formation of microthrombi, influencing the new symptom onset[10].    
Ulcerated plaques in both ACS and SCS groups significantly correlate (p < 0.0001 and p < 0.05, 
respectively) with the onset of all neurological events. New neurological events were more frequent in the 
SCS than in the ACS group during the follow-up. Ballota et al. found a statistically higher incidence of 
ulcerated plaques among the symptomatic (p < 0.01) than asymptomatic stenoses[21]. Wilterdink and 
Easton studied carotid stenoses over 50% and reported 1.3% CVI incidence for asymptomatic pts and 
2.2–9% for the symptomatic pts[22]. 
Various plaque types have a different influence on the onset of new neurological events. In the ACS 
group, calcified and fibrous plaques (p < 0.05 and p = 0.05, respectively) are among plaques that 
remained asymptomatic. The most frequent new symptoms were reported in the mixed plaque group (p < 
0.0001). This complies with results of Nandalur et al., who found that calcified plaques were 21 times less 
likely to be symptomatic than the noncalcified plaques (p < 0.05)[23]. Tegos et al. found that 
asymptomatic stenoses have been predominantly fibrous, while in symptomatic cases, mixed and 
ulcerated plaques prevailed, the latter often being involved in endoluminal thrombi growth and thus a 
source of embolization[24,25]. 
In both ACS and SCS groups, the number of CVI and deaths increased after 12 and 36 months, but 
significantly more in the SCS than ACS group (p < 0.05 and p < 0.0001, respectively). Tegos et al. and 
Kalogeropoulos et al. found that symptomatic stenoses were more often of high degree and unstable type, 
and thus associated with more frequent onset of new neurological events[24,26]. 
CONCLUSION  
This study suggests that among the local morphologic and hemodynamic characteristics of the carotid 
plaque, significant correlation in predicting the neurological events onset and deaths was shown for 
stenosis degree over 70%, ulcerated type plaque, mixed type plaque, increased peak systolic velocity over 
210 cm/sec, increased end diastolic flow velocity over 110 cm/sec, stenosis degree over 50%, and reduced 
blood flow volume at the stenosis site. Among the general cardiovascular risk factors, only lower HDL 
level significantly correlated with presence of the carotid mixed type plaque in the ACS group.  
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